p185HER2 overexpression and HER2 oncogene amplification in recurrent vulvar Paget's disease

Modern Pathology

Volumn 18, Issue 3, 2005, Pages 354-357

  Reich, Olaf ^a,b   Liegl, Bernadette ^a   Tamussino, Karl ^a   Regauer, Sigrid ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

HER2; Immunotherapy; p185; Paget's disease; Trastuzumab; Treatment; Vulva

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P185;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE NEU; PAGET SKIN DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; BIOSYNTHESIS; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR RECURRENCE; VULVA TUMOR;

AGED; FEMALE; GENE AMPLIFICATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAGET'S DISEASE, EXTRAMAMMARY; RECEPTOR, ERBB-2; VULVAR NEOPLASMS;

EID: 15444365877     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800243     Document Type: Article

References (13)

1. Fanning J, Lambert L, Hale M, et al. Paget's disease of the vulva-prevalence of associated vulvar adenocarcinoma, invasive Paget's disease and recurrence after surgical excision. Am J Obstet Gynecol 1999;180:24-27.
2. Kodama S, Kaneko T, Saito M, et al. A clinicopathologic study of 30 patients with Paget's disease of the vulva. Gynecol Oncol 1995;56:63-70.
3. Sarmiento JM, Wolff BG, Burgart LJ, et al. Paget's disease of the perianal region-an aggressive disease? Dis Colon Rectum 1997;40:1187-1194.
4. Green MC, Murray JL, Hortobagyi GN. Monoclonal antibody therapy for solid tumors. Cancer Treat Rev 2000;26:269-286.
5. Tanskanen M, Jahkola T, Asko-Seljavaara S, et al. HER2 oncogene amplification in extramammary Paget's disease. Histopathology 2003;42:575-579.
6. Lammie GA, Barnes DM, Millid W, et al. An immunohistochemical study of the presence of c-erbB-2 protein in Paget's disease. Histopathology 1989;15:505-514.
7. Keatings L, Sinclair J, Wright C, et al. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study. Histopathology 1990;17:243-247.
8. Meissner K, Riviere A, Haupt G, et al. Study of HERneu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. Am J Pathol 1990;137:1305-1309.
9. Wolber RA, Dypuis BA, Wick MR. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease. Am J Clin Pathol 1991;96:243-247.
10. Misas JE, Larson JE, Podczaski E, et al. Recurrent Paget's disease of the vulva in an split-thickness graft. Obstet Gynecol 1990;76:543-544.
11. Schelfhout VR, Coene ED, Delaey B, et al. Pathogenesis of Paget's disease: epidermal heregulin-alpha factor, and the HER receptor family. J Natl Cancer Inst 2000;92:622-628.
12. Vogel CL, Cobleigh MA, Tripathy D, et al. Efficacy and safety of trastuzumab as a single agent in first line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 2002;20:719-726.
13. Carter P, Presta L, Gorman CM, et al. Humanization of an anti-p185 HER antibody for human cancer therapy. Proc Natl Acad Sci USA 1992;89:4285-4289.